BRIEF-Otsuka's JYNARQUE Approved By FDA As First Treatment to Slow Kidney Function Decline

* U.S. FDA APPROVED JYNARQUE AS DRUG TREATMENT TO SLOW KIDNEY FUNCTION DECLINE IN ADULTS AT RISK OF RAPIDLY PROGRESSING ADPKD Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.